The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 535.00
Bid: 350.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 186.40 (53.257%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 535.00
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment and Retirement

18 Aug 2022 07:00

RNS Number : 3906W
B&M European Value Retail S.A.
18 August 2022
 

 

18 August 2022

B&M European Value Retail S.A.

Board Appointment and Retirement

 

B&M European Value Retail S.A. (the "Company") announces the following Board changes.

 

Oliver Tant is to be appointed, subject to shareholder approval, as a Non-Executive Director of the Company with effect from 1 November 2022 when he will also join the Audit & Risk and Nomination Committees. At the conclusion of the Company's AGM in July 2023, it is intended that Oliver will succeed Ron McMillan as the Chair of the Audit & Risk Committee. Ron will by then have served over nine years as a Non-Executive Director and accordingly will be retiring from the Board.

 

Oliver Tant was Chief Financial Officer ("CFO") of FTSE 30 global consumer and international tobacco company Imperial Brands PLC from 2013 to 2021. Oliver had responsibility for the full range of finance functions along with the corporate development, legal, science, IT and procurement teams. During his time at Imperial, Oliver made a significant contribution to the transformation and development of the business.

 

Oliver is currently a Non-Executive Director and Audit Committee Chair designate of Redrow plc. Oliver is also currently working with Brookfield Asset Management where he is providing financial consulting services to their portfolio company Modulaire Group.

 

Prior to joining Imperial, Oliver spent over 30 years with KPMG. He was a partner from 1994 (covering audit, transaction and advisory services) and from 2005 was co-lead of the Financial Advisory business. From 2009 to 2012 Oliver was UK Head of Audit. Oliver also served on KPMG's international executive committee for a period of four years.

 

For the last four years Ron McMillan has also held the role of Senior Independent Director. A separate announcement will be made in due course in relation to the succession plan for this role.

 

 

Peter Bamford, Chairman, said

 "I am delighted that Oliver has agreed to join the Board of B&M. His previous roles at Imperial Brands and KPMG give the combined experience of a Big Four audit partner with eight years as CFO of a FTSE 100 business. I am sure that he will add a great deal of value both as a Non-Executive Director and in his future role as Audit & Risk Committee Chair.

 

Ron has been an outstanding Chair of the Audit & Risk Committee and has played a critical role in the successful transition of B&M from IPO in 2014 to a FTSE 100 company. However, it is now right that we plan for his succession. On behalf of the Board, I would like to thank Ron for his service to B&M and look forward to working with him over the remaining period of his directorship."

With regard to Oliver Tant's appointment to the Board on 1 November 2022, as there is currently no vacancy in the office of a Director of the Company, in accordance with Luxembourg law, his appointment is required to be approved by a resolution of shareholders at a general meeting of the Company. Accordingly, an Ordinary General Meeting of shareholders is to be convened during October 2022 (the "Meeting") for that purpose. Subject to his appointment being approved at the Meeting, it will take effect on 1 November 2022. Further announcements will be made to confirm when the notice of the Meeting has been despatched to shareholders, and also following the Meeting to confirm the outcome of the resolution to approve the appointment.

 

The Company makes this announcement in accordance with LR 9.6.11R of the Listing Rules. There are no other matters to be disclosed under LR9.6.13R in relation to the appointment of Oliver Tant.

 

Enquiries

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive Officer

Alex Russo, Chief Financial Officer

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland

Sam Cartwright

bmstores-maitland@maitland.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFIDTSIDLIF
Date   Source Headline
4th Dec 20207:00 amRNSResult of EGM
3rd Dec 20204:20 pmRNSTrading Update
17th Nov 202012:39 pmRNSDirector/PDMR Shareholding
16th Nov 202011:12 amRNSDirector/PDMR Shareholding
13th Nov 202012:35 pmRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSHalf-year Report
28th Oct 20207:00 amRNSNotice of EGM
30th Sep 20209:36 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSTrading Update
21st Sep 20209:53 amRNSResult of AGM
1st Sep 20209:40 amRNSTotal Voting Rights
30th Jul 202011:20 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSTrading Statement
20th Jul 20209:00 amRNSPost Stabilisation Notice
14th Jul 20209:50 amRNSDirector/PDMR Shareholding
13th Jul 20209:09 amRNSBlock listing Interim Review
9th Jul 20202:28 pmRNSBoard Changes
7th Jul 20204:05 pmRNSHolding(s) in Company
7th Jul 20209:01 amRNSHolding(s) in Company
2nd Jul 20206:19 pmRNSPricing of Senior Secured Notes Offering
1st Jul 202011:07 amRNSPre Stabilisation Notice
1st Jul 20209:02 amRNSLaunch of Senior Secured Notes Offering
1st Jul 20207:00 amRNSTrading Statement
1st Jul 20207:00 amRNSAnnual Financial Report
17th Jun 202011:38 amRNSDirector/PDMR Shareholding
11th Jun 20207:00 amRNSPreliminary Results
29th May 20207:00 amRNSTrading Update
27th May 20209:57 amRNSHolding(s) in Company
1st Apr 20204:17 pmRNSHolding(s) in Company
1st Apr 202012:29 pmRNSCovid-19 Update
27th Mar 202012:05 pmRNSCompletion of Disposal
25th Mar 20202:50 pmRNSHolding(s) in Company
19th Mar 20202:42 pmRNSHolding(s) in Company
11th Mar 20207:00 amRNSDisposal
6th Mar 20206:02 pmRNSSpecial Dividend
3rd Mar 20207:00 amRNSBoard Changes
24th Feb 20209:54 amRNSHolding(s) in Company
14th Jan 202010:10 amRNSHolding(s) in Company
13th Jan 202010:00 amRNSBlock listing Interim Review
10th Jan 20207:00 amRNSTrading Statement
11th Dec 201911:10 amRNSHolding(s) in Company
11th Dec 201911:01 amRNSHolding(s) in Company
2nd Dec 201910:33 amRNSTotal Voting Rights
12th Nov 20197:00 amRNSHalf-year Report
16th Oct 201912:50 pmRNSBoard Retirement
2nd Aug 20193:28 pmRNSDirector/PDMR Shareholding
31st Jul 20199:14 amRNSHolding(s) in Company
29th Jul 201910:40 amRNSResult of AGM
25th Jul 20197:00 amRNSDirector/PDMR Shareholding
24th Jul 20197:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.